Evidence map›Paper›PMID 41810409›Full record

ArticleFrontiers in veterinary science2026

OncoCan: a liquid biopsy assay for cell-free DNA quantification in canine plasma to support cancer prognosis.

Sánchez Virginia, Farreny Gal la, Martinez-Merlo Elena, Trancon Sara, Montañés José Carlos, Enriquez Laura, Aguirrebeña Arantxa, Arasanz Duque Agustín, Noce Antonia

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Sánchez Virginia *Complutense Veterinary Teaching Hospital and Department of Animal Medicine and Surgery, Veterinary Medicine School, Complutense University of Madrid, Madrid, Spain.
Farreny Gal la *Omica Biomed, Barcelona, Spain.
Martinez-Merlo ElenaComplutense Veterinary Teaching Hospital and Department of Animal Medicine and Surgery, Veterinary Medicine School, Complutense University of Madrid, Madrid, Spain.
Trancon SaraComplutense Veterinary Teaching Hospital and Department of Animal Medicine and Surgery, Veterinary Medicine School, Complutense University of Madrid, Madrid, Spain.
Montañés José CarlosMolecular Biology Core, Hospital Clínic of Barcelona, Barcelona, Spain.
Enriquez LauraOmica Biomed, Barcelona, Spain.
Aguirrebeña ArantxaOmica Biomed, Barcelona, Spain.
Arasanz Duque AgustínOmica Biomed, Barcelona, Spain.
Noce AntoniaOmica Biomed, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early cancer detection remains a major challenge in veterinary medicine. Cell-free DNA (cfDNA), released into the bloodstream through apoptosis, necrosis, or circulating tumor cells, can be quantified non-invasively via liquid biopsy and is already established in human oncology. In this study, we evaluated OncoCan, a targeted plasma cfDNA assay, by analyzing samples from 83 dogs with various neoplasms and 47 healthy controls to assess diagnostic and prognostic utility. Wilcoxon rank-sum testing revealed significantly higher cfDNA concentrations in neoplastic versus healthy samples (

Indexed as

cancercfDNAdogsliquid biopsyprognosis

Identifiers

PMID41810409
PMCPMC12970012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.